Covance aims to increase big pharma win rate to drive growth
Covance outlines plans to use oncology capabilities to win more business from big pharma.
Covance outlines plans to use oncology capabilities to win more business from big pharma.
SCOPE 2020
The two firms have joined forces on technology designed to streamline collaboration between sites and sponsors.
Abbott’s glucose sensing technology and a tubeless insulin delivery system developed by Insulet are set to create a personalized diabetes management solution.
Taro instigates a voluntary recall of phenytoin oral suspension after two lots are found not to re-suspend when shaken.
Dermapharm will pick up the business unit for an unspecified fee, whilst Merck will retain the development of its adrenaline autoinjector project.